$PACK

Ranpak Q2 Earnings Call Highlights

Ranpak (NYSE:PACK) reported Q2 results on an earnings call. Management said constant-currency net revenue rose 15.4% in Europe and Asia-Pacific, with automation revenue up 103.7% and PPS volumes up 2.4% YoY. Adjusted EBITDA increased $2.6M to $19.1M; gross margin improved 150 bps. Ranpak expects automation adjusted EBITDA breakeven late 2026 and EBITDA-positive in 2027.

Original reporting
Published Aug 2, 2026, 7:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 2, 2026, 8:41 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ranpak Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$PACKBullishMed
01

Why it matters

Key takeaways are strong automation revenue growth, improving North American PPS margins from efficiency gains, and a stated plan to reach automation adjusted EBITDA breakeven late 2026 and EBITDA-positive in 2027. Offsets include European margin pressure from input-cost timing versus surcharge implementation and product-mix pressure from lower-priced void-fill.

02

Market read

For PACK, the most tradable elements are the quantified automation acceleration, margin improvement commentary, and explicit multi-year automation profitability milestones.

03

What to watch

The text notes a temporary European surcharge and potential portfolio pruning in North America; traders may need to watch whether these actions translate into sustained gross margin rather than one-off timing effects.

Relevance 7/10Novelty 6/10Timing: pre-market today, Q2 earnings call highlights and 2026-2027 automation profitability timeline

Background

The piece summarizes Ranpak’s Q2 earnings call, focusing on PPS volumes, automation growth, margin drivers, and liquidity/capex plus longer-term targets.

Company-level read

Ticker impact

$PACKBullishMedium confidence
Context

Ranpak said automation revenue surged 103.7% and guided automation to adjusted EBITDA breakeven late 2026 and EBITDA-positive in 2027.

Expected impact

Moderate positive bias for PACK as investors weigh automation scale-up and margin progress against European margin pressure and mix shift.

Evidence & confidence

The article provides multiple quantified operating/margin datapoints plus explicit automation profitability timing, which can re-rate expectations even without a full earnings table.

Market effects

Supports the view that sustainable paper-based packaging demand and automation adoption are strengthening, while void-fill mix and input-cost pass-through remain key swing factors.

Highlights Europe outperformance in PPS volumes but margin pressure from input-cost timing and customer surcharge mechanics.

Reinforces broader packaging and industrial automation themes tied to energy costs, inflation, and customer cost-reduction priorities.

Counterpoint

Automation margin profile is described as lower and dependent on scaling; Europe mix shift toward lower-priced void-fill could cap consolidated margin gains.

Key entities

  • Ranpak Holdings Corp.

    NYSE-listed packaging and automation provider; reported Q2 call highlights including automation growth, margin drivers, and automation profitability timeline.

  • Bill Drew

    CFO cited North American PPS margin improvement and efficiency gains during the quarter.

  • Asali

    Management speaker who discussed regional performance, customer reception for Guardian 24, and automation breakeven/EBITDA-positive timing.

Related articles

$PACKMed

Ranpak Holdings Corp. (PACK): Results of Operations and Financial Condition

Ranpak Holdings Corp. (PACK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a04pack-202606xex99x1.htm EX-99.1 Document Exhibit 99.1 Ranpak Holdings Corp. Reports Second Quarter 2026 Financial Results • Net revenue for the second quarter increased 14.0% year over year to $105.2 million and increased 12.2% year over year on a constant currency ba

$PACKMedAI 8/10

Ranpak (NYSE:PACK) Reaches New 1

Ranpak Holdings (NYSE:PACK) hit a new 52-week high on Tuesday, trading up to $6.67 and last at $6.62 versus a prior close of $6.28. The article cites recent analyst actions including UBS and Cantor reiterating “overweight,” while Wall Street Zen raised PACK to “hold.” MarketBeat shows a “Moderate Buy” consensus and $6.83 target. In its April 30 earnings, Ranpak reported EPS of -$0.12 and revenue of $101.2M.

$TLRYMed

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.

$MDTMedAI 8/10

Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?

Medtronic (MDT) and Tenet Healthcare (THC) present distinct growth prospects. MDT reported its highest annual revenue growth in a decade, driven by cardiac ablation solutions and investments in innovation. THC saw a 52.2% increase in adjusted EPS and 6.8% revenue growth, with margin expansion in hospitals. Investors must choose between MDT's innovation-led recovery and THC's operational improvements.